| Produktname | Tirzepatid |
|---|---|
| CAS-Nummer | 2023788-19-2 |
| Molekülformel | C225H348N48O68 |
| Molekulargewicht | 4813.45 g/mol |
| Aussehen | Weißes bis cremefarbenes Pulver |
| Reinheit | ≥98% (HPLC) |
| Löslichkeit | Soluble in water, DMSO, and ethanol |
| Paket | 1g, 5g, 10g, 100g, or custom |
Brauchst du Hilfe? Kontaktieren Sie unser Team

Synonyms: Tirzepatide, 2023788-19-2, GIP/GLP-1 receptor agonist, LY3298176, Mounjaro, Zepbound, Glucagon-like peptide-1 receptor agonist
Tirzepatide has been making headlines in the pharmaceutical world as a first-in-class dual agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Originally developed by Eli Lilly and approved for type 2 diabetes under the brand name Mounjaro, it has quickly become a cornerstone in metabolic disease management, with expanding applications in obesity and cardiovascular health. Its unique mechanism not only enhances glycemic control but also delivers superior weight loss outcomes, which has positioned it as one of the most anticipated peptide therapeutics of the decade.
At LyvBio, we supply high-purity Tirzepatide (≥98% by HPLC) in research and development quantities, meeting strict quality criteria. Our product is available as a lyophilized powder, ideal for reconstitution in laboratory settings. Whether you’re conducting preclinical studies, formulation development, or analytical method validation, our Tirzepatide offers reliable performance and comprehensive documentation.
Our product is supplied as a white to off-white powder, freely soluble in water and common organic solvents. Each batch is characterized by mass spectrometry and HPLC to confirm identity and purity, ensuring that researchers receive a consistent and reliable material for their studies.
| Parameter | Technische Daten |
|---|---|
| Analyse (HPLC) | ≥98,01 TP3T |
| Aussehen | Weißes bis cremefarbenes Pulver |
| Trocknungsverlust | ≤5,0% |
| Schwermetalle | ≤ 10 ppm |
| Purity (related substances) | Meets internal requirements |